Advertisement

Advertisement

JP:4588 Stock Latest News

Oncolys BioPharma Surges in Sales but Keeps Forecast and Dividends on Hold

Company AnnouncementsOncolys BioPharma Surges in Sales but Keeps Forecast and Dividends on Hold

Oncolys Wins Full Japanese Approval for First Oncolytic Virus in Esophageal Cancer

PremiumCompany Announcements

Oncolys Wins Full Japanese Approval for First Oncolytic Virus in Esophageal Cancer

2M ago

Oncolys BioPharma Narrows Quarterly Loss but Withholds 2026 Forecast

PremiumCompany Announcements

Oncolys BioPharma Narrows Quarterly Loss but Withholds 2026 Forecast

3M ago

Oncolys BioPharma Reports Decline in Financial Performance for 2025

PremiumCompany Announcements

Oncolys BioPharma Reports Decline in Financial Performance for 2025

9M ago

Oncolys BioPharma Reports Increased Losses in H1 2025

PremiumCompany Announcements

Oncolys BioPharma Reports Increased Losses in H1 2025

1y ago

Oncolys BioPharma Reports Decline in Q1 2025 Financial Results

PremiumCompany AnnouncementsOncolys BioPharma Reports Decline in Q1 2025 Financial Results

1y ago

Oncolys BioPharma Reports 2024 Financial Results Highlighting Improved Equity Ratio

Company Announcements

Oncolys BioPharma Reports 2024 Financial Results Highlighting Improved Equity Ratio

2y ago

Oncolys BioPharma’s Telomelysin Shows Promising Results in Phase I Trial

Company Announcements

Oncolys BioPharma’s Telomelysin Shows Promising Results in Phase I Trial

2y ago

Oncolys BioPharma Reports Decline in Sales Amidst Uncertainty

PremiumCompany Announcements

Oncolys BioPharma Reports Decline in Sales Amidst Uncertainty

2y ago

Oncolys BioPharma Faces Decreased Sales and Losses

PremiumCompany Announcements

Oncolys BioPharma Faces Decreased Sales and Losses

2y ago

Oncolys Finalizes Trial Enrollment for Cancer Therapy

PremiumCompany Announcements

Oncolys Finalizes Trial Enrollment for Cancer Therapy

2y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >